DNA topoisomerase-targeting antitumor drugs can be studied in yeast - PubMed (original) (raw)
DNA topoisomerase-targeting antitumor drugs can be studied in yeast
J Nitiss et al. Proc Natl Acad Sci U S A. 1988 Oct.
Abstract
The antitumor drugs camptothecin and an anilinoacridine, 4'-(9-acridinylamino)-methanesulfon-m-anisidide (mAMSA), which act on DNA topoisomerase I and II, respectively, are shown to inhibit the growth of Saccharomyces cerevisiae mutants selected for their permeability to other inhibitors. In addition to growth inhibition, these drugs induce high levels of homologous recombination and induce the expression of a DNA damage-inducible gene DIN3. Cytotoxicity of the drugs is more pronounced in strains that also carry a rad52 mutation. An analog of mAMSA), which is ineffective as an inhibitor of DNA topoisomerase II in mammalian cells, is also ineffective in eliciting physiological responses in these yeast strains. The physiological effects of camptothecin, but not those of mAMSA, disappear if the TOP1 gene encoding DNA topoisomerase I is disrupted. This shows that DNA topoisomerase I is the sole target of camptothecin cytotoxicity and illustrates that a nonessential enzyme can nevertheless be the target for a cytotoxic drug.
Similar articles
- Roles of nonhomologous end-joining pathways in surviving topoisomerase II-mediated DNA damage.
Malik M, Nitiss KC, Enriquez-Rios V, Nitiss JL. Malik M, et al. Mol Cancer Ther. 2006 Jun;5(6):1405-14. doi: 10.1158/1535-7163.MCT-05-0263. Mol Cancer Ther. 2006. PMID: 16818498 - Altered topoisomerase I activity and recombination activating gene expression in a human leukemia cell line resistant to doxorubicin.
Riou JF, Grondard L, Petitgenet O, Abitbol M, Lavelle F. Riou JF, et al. Biochem Pharmacol. 1993 Sep 1;46(5):851-61. doi: 10.1016/0006-2952(93)90494-h. Biochem Pharmacol. 1993. PMID: 8396937 - Using yeast to understand drugs that target topoisomerases.
Nitiss JL, Rose A, Sykes KC, Harris J, Zhou J. Nitiss JL, et al. Ann N Y Acad Sci. 1996 Dec 13;803:32-43. doi: 10.1111/j.1749-6632.1996.tb26374.x. Ann N Y Acad Sci. 1996. PMID: 8993498 Review. No abstract available. - Yeast Saccharomyces cerevisiae as a model system to study the cytotoxic activity of the antitumor drug camptothecin.
Bjornsti MA, Knab AM, Benedetti P. Bjornsti MA, et al. Cancer Chemother Pharmacol. 1994;34 Suppl:S1-5. doi: 10.1007/BF00684856. Cancer Chemother Pharmacol. 1994. PMID: 8070016 Review.
Cited by
- Neurotoxin-induced DNA damage is persistent in SH-SY5Y cells and LC neurons.
Wang Y, Musich PR, Cui K, Zou Y, Zhu MY. Wang Y, et al. Neurotox Res. 2015 May;27(4):368-83. doi: 10.1007/s12640-015-9521-4. Epub 2015 Mar 1. Neurotox Res. 2015. PMID: 25724887 Free PMC article. - Repair of DNA strand breaks by the overlapping functions of lesion-specific and non-lesion-specific DNA 3' phosphatases.
Vance JR, Wilson TE. Vance JR, et al. Mol Cell Biol. 2001 Nov;21(21):7191-8. doi: 10.1128/MCB.21.21.7191-7198.2001. Mol Cell Biol. 2001. PMID: 11585902 Free PMC article. - Repair of topoisomerase I covalent complexes in the absence of the tyrosyl-DNA phosphodiesterase Tdp1.
Liu C, Pouliot JJ, Nash HA. Liu C, et al. Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14970-5. doi: 10.1073/pnas.182557199. Epub 2002 Oct 23. Proc Natl Acad Sci U S A. 2002. PMID: 12397185 Free PMC article. - Yeast recombination pathways triggered by topoisomerase II-mediated DNA breaks.
Sabourin M, Nitiss JL, Nitiss KC, Tatebayashi K, Ikeda H, Osheroff N. Sabourin M, et al. Nucleic Acids Res. 2003 Aug 1;31(15):4373-84. doi: 10.1093/nar/gkg497. Nucleic Acids Res. 2003. PMID: 12888496 Free PMC article. - Unexpected function of the glucanosyltransferase Gas1 in the DNA damage response linked to histone H3 acetyltransferases in Saccharomyces cerevisiae.
Eustice M, Pillus L. Eustice M, et al. Genetics. 2014 Apr;196(4):1029-39. doi: 10.1534/genetics.113.158824. Epub 2014 Feb 13. Genetics. 2014. PMID: 24532730 Free PMC article.
References
- Cancer Treat Rep. 1976 May;60(5):637-8 - PubMed
- Biochemistry. 1988 Apr 5;27(7):2253-9 - PubMed
- J Bacteriol. 1983 Jan;153(1):163-8 - PubMed
- Methods Enzymol. 1983;101:202-11 - PubMed
- Methods Enzymol. 1983;101:253-69 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials